Literature DB >> 15149149

Diffusion-weighted MR imaging in the evaluation of renal tumours.

E Squillaci1, G Manenti, F Di Stefano, R Miano, L Strigari, G Simonetti.   

Abstract

The aim of this study was to evaluate the capability and the reliability of diffusion-weighted MR imaging to differentiate benign from malignant renal lesions. Twenty healthy volunteers and 48 patients with known renal lesions underwent MR of the kidneys by using a 1.5 T superconductive magnet. Diffusion-weighted images (DWI) were obtained on the axial plane during breathhold (17 s) with a SE EPI single shot sequence using a b value of 500 s/mm2. One region of interest (ROI) (lesions < than 3 cm) or 3 ROI (lesions > than 3 cm) were placed within the lesion for the measurement of apparent diffusion coefficient (ADC). ADC map was obtained at each slice position. Mean ADC value in normal renal parenchyma was 2.2 +/- 0.20 x 10(-3) mm2/s, while ADC values in simple cysts (n = 20) were higher (mean ADC values 3.65 +/- 0.09 x 10(-3) mm2/s). Solid benign and malignant renal tumors (n = 19) showed a mean ADC value of 1.7 +/- 0.48 x 10(-3) mm2/sec. The comparison between ADC values in normal parenchyma group and tumour group were found to be statistically significant (p < 0.0001). ADC values of cystic renal cell carcinomas were higher than those of clear cell carcinomas (p < 0.001). In conclusion, DW MRI of the kidney seems to be a reliable means for differentiating normal renal parenchyma from different renal tumors.

Entities:  

Mesh:

Year:  2004        PMID: 15149149

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  29 in total

Review 1.  Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?

Authors:  Robert S Lim; Trevor A Flood; Matthew D F McInnes; Luke T Lavallee; Nicola Schieda
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Diffusion tensor imaging and tractography of the kidney in children: feasibility and preliminary experience.

Authors:  Camilo Jaimes; Kassa Darge; Dmitry Khrichenko; Robert H Carson; Jeffrey I Berman
Journal:  Pediatr Radiol       Date:  2014-01

Review 3.  Extracranial applications of diffusion-weighted magnetic resonance imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

4.  The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.

Authors:  S Avcu; M N Koseoglu; K Ceylan; M D Bulut; M Dbulutand; O Unal
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

Review 5.  Diffusion weighted magnetic resonance imaging and its recent trend-a survey.

Authors:  Geetha Soujanya Chilla; Cher Heng Tan; Chenjie Xu; Chueh Loo Poh
Journal:  Quant Imaging Med Surg       Date:  2015-06

Review 6.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

7.  Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T.

Authors:  G Manenti; M Di Roma; S Mancino; D A Bartolucci; G Palmieri; R Mastrangeli; R Miano; E Squillaci; G Simonetti
Journal:  Radiol Med       Date:  2008-04-02       Impact factor: 3.469

8.  Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study.

Authors:  Xueqin Xu; Wenqiang Fang; Huawei Ling; Weimin Chai; Kemin Chen
Journal:  Eur Radiol       Date:  2009-09-30       Impact factor: 5.315

9.  Role of new magnetic resonance imaging modalities in diagnosis of orbital masses: a clinicopathologic correlation.

Authors:  Nader Roshdy; Maha Shahin; Hanem Kishk; Sherif El-Khouly; Amany Mousa; Iman Elsalekh
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

Review 10.  DW-MRI of the urogenital tract: applications in oncology.

Authors:  G Petralia; H C Thoeny
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.